Home » Topics » Conferences

Conferences
RSS

Lamotrigine effective in HIV-associated painful sensory polyneuropathy

April 28, 1999

Improvement in spasticity noted with small doses of Zanaflex

April 28, 1999

Preliminary evidence of efficacy and safety of N-acetylcysteine in AD

April 28, 1999

Spotlight on IL-5 as a target for the treatment of inflammatory diseases

April 28, 1999

Noncompetitive AMPA antagonist potentiates levodopa activity in primate PD model

April 27, 1999

Pregabalin: first clinical experience in patients with refractory complex partial seizures

April 27, 1999

Muscarinic agonists fail to improve cognitive function in AD

April 27, 1999

BRAINS results presented at American Academy of Neurology meeting

April 27, 1999

Anti-CD11/CD18 MAb not effective in phase II trial in exacerbations of MS

April 27, 1999

Donor bone marrow: an alternative to immunosuppressive drugs in transplantation?

April 26, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...